• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

mesothelioma

success failure signposts
Biotech

Ultimovacs links BMS-cancer vaccine combo to improved survival

Ultimovacs hit back with data showing adding its vaccine to two Bristol Myers Squibb drugs improved survival in people with cancer of the lung lining.
Nick Paul Taylor Oct 18, 2023 8:40am
ATOM plant

Atara reviewing patient death in mesothelioma CAR-T study

Feb 18, 2022 1:05pm
Cancer cells reproduction

Biopharma charts progress in translating CAR-T to solid cancers

Dec 15, 2021 3:00am
artificial intelligence chip

Sanofi inks $270M cancer AI deal with developer Owkin

Nov 18, 2021 1:30am
Cancer cells reproduction

SITC: Cellectis off-the-shelf CAR-T active in solid tumor models

Nov 12, 2021 10:50am
cash  money

Cedilla adds $25M to series B to test two cancer drugs in trials

Oct 25, 2021 6:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings